{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:31:01Z","timestamp":1785825061828,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,12,27]],"date-time":"2014-12-27T00:00:00Z","timestamp":1419638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00216-014-8402-7","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T03:56:14Z","timestamp":1419566174000},"page":"2283-2291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Fabry disease: renal sphingolipid distribution in the \u03b1-Gal A knockout mouse model by mass spectrometric and immunohistochemical imaging"],"prefix":"10.1007","volume":"407","author":[{"given":"Ladislav","family":"Kuchar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Faltyskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Krasny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dobrovolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Hulkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Ledvinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Volny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Strohalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Lemr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Kryspinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Befekadu","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Rybov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Havlicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,27]]},"reference":[{"key":"8402_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","volume":"33","author":"H Poupetova","year":"2010","unstructured":"Poupetova H, Ledvinova J, Berna L, Dvorakova L, Kozich V, Elleder M (2010) The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 33:387\u2013396","journal-title":"J Inherit Metab Dis"},{"key":"8402_CR2","volume-title":"Alpha-galactosidase A deficiency: Fabry disease. The metabolic and molecular bases of inherited disease","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (eds) (2001) Alpha-galactosidase A deficiency: Fabry disease. The metabolic and molecular bases of inherited disease. McGraw-Hill, New York"},{"key":"8402_CR3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","volume":"1802","author":"SM Rombach","year":"2010","unstructured":"Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, Kuiper S, Weerrnan MAB, Groener JEM, Poorthuis BJ, Hollak CEM, Aerts JMFG (2010) Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta-Mol Basis Dis 1802:741\u2013748","journal-title":"Biochim Biophys Acta-Mol Basis Dis"},{"key":"8402_CR4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","volume":"417","author":"M Elleder","year":"1990","unstructured":"Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermannkuhn B, Ledvinova J, Belohlavek, Kral V, Dorazilova V (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry disease\u2014report on a case simulating hypertrophic nonobstructive cardiomyopathy. Virchows Archiv A: Pathol Anat Histopathol 417:449\u2013455","journal-title":"Virchows Archiv A: Pathol Anat Histopathol"},{"key":"8402_CR5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00216-005-3239-8","volume":"382","author":"D Touboul","year":"2005","unstructured":"Touboul D, Roy S, Germain D, Baillet A, Brion F, Prognon P, Chaminade P, Laprevote O (2005) Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease. Anal Bioanal Chem 382:1209\u20131216","journal-title":"Anal Bioanal Chem"},{"key":"8402_CR6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","volume":"149A","author":"L Kuchar","year":"2009","unstructured":"Kuchar L, Ledvinova J, Hrebicek M, Myskova H, Dvorakova L, Berna L, Chrastina P, Asfaw B, Elleder M, Petermoeller M, Mayrhofer H, Staudt M, Kraegeloh-Mann I, Paton BC, Harzer K (2009) Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations. Am J Med Genet A 149A:613\u2013621","journal-title":"Am J Med Genet A"},{"key":"8402_CR7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1373\/clinchem.2004.041418","volume":"51","author":"M Fuller","year":"2005","unstructured":"Fuller M, Sharp PC, Rozaklis T, Whitfield PD, Blacklock D, Hopwood JJ, Meikle PJ (2005) Urinary lipid profiling for the identification of Fabry hemizygotes and heterozygotes. Clin Chem 51:688\u2013694","journal-title":"Clin Chem"},{"key":"8402_CR8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ymgme.2005.01.007","volume":"85","author":"T Kitagawa","year":"2005","unstructured":"Kitagawa T, Ishige N, Suzuki K, Owada M, Ohashi T, Kobayashi M, Eto Y, Tanaka A, Mills K, Winchester B, Keutzer J (2005) Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry. Mol Genet Metab 85:196\u2013202","journal-title":"Mol Genet Metab"},{"key":"8402_CR9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00467-008-0846-6","volume":"23","author":"T Kitagawa","year":"2008","unstructured":"Kitagawa T, Suzuki K, Ishige N, Ohashi T, Kobayashi M, Eto Y, Tanaka A, Odaka H, Owada M (2008) Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes. Pediatr Nephrol 23:1461\u20131471","journal-title":"Pediatr Nephrol"},{"key":"8402_CR10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R, Dvorakova L, Ledvinova J, Magage S, Bultas J, Lubanda JC, Elleder M, Karetova D, Pavlikova M, Hrebicek M (2005) Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med 83:647\u2013654","journal-title":"J Mol Med"},{"key":"8402_CR11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2012.192138","volume":"59","author":"H Gold","year":"2013","unstructured":"Gold H, Mirzaian M, Dekker N, Ferraz MJ, Lugtenburg J, Codee JDC, van der Marel GA, Overkleeft HS, Linthorst GE, Groener JEM, Aerts JM, Poorthuis B (2013) Quantification of globotriaosylsphingosine in plasma and urine of Fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry. Clin Chem 59:547\u2013556","journal-title":"Clin Chem"},{"key":"8402_CR12","series-title":"JIMD Reports","first-page":"99","volume-title":"Jimd reports\u2014case and research reports, 2012\/4","author":"M Niemann","year":"2013","unstructured":"Niemann M, Rolfs A, Giese A, Mascher H, Breunig F, Ertl G, Wanner C, Weidemann F (2013) Lyso-Gb3 indicates that the alpha-galactosidase A mutation D313Y is not clinically relevant for Fabry disease. In: Zschocke J, Gibson KM, Brown G, Morava E, Peters V (eds) Jimd reports\u2014case and research reports, 2012\/4, vol 7, JIMD Reports. Springer, Berlin, pp 99\u2013102. doi: 10.1007\/8904_2012_154"},{"key":"8402_CR13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijms.2006.09.027","volume":"260","author":"D Touboul","year":"2007","unstructured":"Touboul D, Roy S, Germain DP, Chaminade P, Brunelle A, Laprevote O (2007) MALDI-TOF and cluster-TOF-SIMS imaging of Fabry disease biomarkers. Int J Mass Spectrom 260:158\u2013165","journal-title":"Int J Mass Spectrom"},{"key":"8402_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1253\/circj.CJ-10-0767","volume":"75","author":"K Onoue","year":"2011","unstructured":"Onoue K, Zaima N, Sugiura Y, Isojima T, Okayama S, Horii M, Akai Y, Uemura S, Takemura G, Sakuraba H, Sakaguchi Y, Setou M, Saito Y (2011) Using imaging mass spectrometry to accurately diagnose Fabry\u2019s disease. Circ J 75:221\u2013223","journal-title":"Circ J"},{"key":"8402_CR15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00467-012-2222-9","volume":"28","author":"B Najafian","year":"2013","unstructured":"Najafian B, Mauer M, Hopkin RJ, Svarstad E (2013) Renal complications of Fabry disease in children. Pediatr Nephrol 28:679\u2013687","journal-title":"Pediatr Nephrol"},{"key":"8402_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","volume":"68","author":"YA Ioannou","year":"2001","unstructured":"Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ (2001) Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet 68:14\u201325","journal-title":"Am J Hum Genet"},{"key":"8402_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00022744-199803000-00002","volume":"6","author":"M Vyberg","year":"1998","unstructured":"Vyberg M, Nielsen S (1998) Dextran polymer conjugate two-step visualization system for immunohistochemistry\u2014a comparison of EnVision + with two three-step avidin-biotin techniques. Appl Immunohistochem 6:3\u201310","journal-title":"Appl Immunohistochem"},{"key":"8402_CR18","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1021\/ac100818g","volume":"82","author":"M Strohalm","year":"2010","unstructured":"Strohalm M, Kavan D, Novak P, Volny M, Havlicek V (2010) MMass 3: a cross-platform software environment for precise analysis of mass spectrometric data. Anal Chem 82:4648\u20134651","journal-title":"Anal Chem"},{"key":"8402_CR19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/glycob\/cws050","volume":"22","author":"H Hulkova","year":"2012","unstructured":"Hulkova H, Ledvinova J, Kuchar L, Smid F, Honzikova J, Elleder M (2012) Glycosphingolipid profile of the apical pole of human placental capillaries: the relevancy of the observed data to Fabry disease. Glycobiology 22:725\u2013732","journal-title":"Glycobiology"},{"key":"8402_CR20","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/rcm.4659","volume":"24","author":"L Kuchar","year":"2010","unstructured":"Kuchar L, Rotkova J, Asfaw B, Lenfeld J, Horak D, Korecka L, Bilkova Z, Ledvinova J (2010) Semisynthesis of C17:0 isoforms of sulphatide and glucosylceramide using immobilised sphingolipid ceramide N-deacylase for application in analytical mass spectrometry. Rapid Commun Mass Spectrom 24:2393\u20132399","journal-title":"Rapid Commun Mass Spectrom"},{"key":"8402_CR21","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1194\/jlr.M017178","volume":"52","author":"B Durant","year":"2011","unstructured":"Durant B, Forni S, Sweetman L, Brignol N, Meng XL, Benjamin ER, Schiffmann R, Shen JS (2011) Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice. J Lipid Res 52:1742\u20131746","journal-title":"J Lipid Res"},{"key":"8402_CR22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.aca.2013.07.060","volume":"794","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang Y, Guo S, Guo Y, Liu H, Li Z (2013) Ammonia-treated N-(1-naphthyl) ethylenediamine dihydrochloride as a novel matrix for rapid quantitative and qualitative determination of serum free fatty acids by matrix-assisted laser desorption\/ionization-Fourier transform ion cyclotron resonance mass spectrometry. Anal Chim Acta 794:82\u201389","journal-title":"Anal Chim Acta"},{"key":"8402_CR23","doi-asserted-by":"crossref","unstructured":"Elleder M (2010) Subcellular, cellular and organ pathology of Fabry disease. In: Elstein et al. (eds) Fabry disease. Springer: Berlin, p 39-79. doi: 10.1007\/978-90-481-9033-1_3","DOI":"10.1007\/978-90-481-9033-1_3"},{"key":"8402_CR24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s10545-008-0900-3","volume":"31","author":"P Vylet\u2019al","year":"2008","unstructured":"Vylet\u2019al P, Hulkova H, Zivna M, Berna L, Novak P, Elleder M, Kmoch S (2008) Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy. J Inherit Metab Dis 31:508\u2013517","journal-title":"J Inherit Metab Dis"},{"key":"8402_CR25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.ajkd.2003.09.022","volume":"43","author":"SM Meehan","year":"2004","unstructured":"Meehan SM, Junsanto T, Rydel JJ, Desnick RJ (2004) Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications. Am J Kidney Dis 43:164\u2013171","journal-title":"Am J Kidney Dis"},{"key":"8402_CR26","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","volume":"94","author":"T Ohshima","year":"1997","unstructured":"Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, Sugimoto Y, Pastan I, Gottesman MM, Brady RO, Kulkarni AB (1997) Alpha-galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci U S A 94:2540\u20132544","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8402_CR27","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","volume":"96","author":"T Ohshima","year":"1999","unstructured":"Ohshima T, Schiffmann R, Murray GJ, Kopp J, Quirk JM, Stahl S, Chan CC, Zerfas P, Tao-Cheng JH, Ward JM, Brady RO, Kulkarni AB (1999) Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice. Proc Natl Acad Sci U S A 96:6423\u20136427","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8402_CR28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00428-011-1051-8","volume":"458","author":"C Valbuena","year":"2011","unstructured":"Valbuena C, Oliveira JP, Carneiro F, Relvas S, Ganhao M, Clara Sa-Miranda M, Rodrigues LG (2011) Kidney histologic alterations in alpha-galactosidase-deficient mice. Virchows Arch 458:477\u2013486","journal-title":"Virchows Arch"},{"key":"8402_CR29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.plipres.2012.12.001","volume":"52","author":"JP Slotte","year":"2013","unstructured":"Slotte JP (2013) Molecular properties of various structurally defined sphingomyelins\u2014correlation of structure with function. Prog Lipid Res 52:206\u2013219","journal-title":"Prog Lipid Res"},{"key":"8402_CR30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.plipres.2013.05.001","volume":"52","author":"JP Slotte","year":"2013","unstructured":"Slotte JP (2013) Biological functions of sphingomyelins. Prog Lipid Res 52:424\u2013437","journal-title":"Prog Lipid Res"},{"key":"8402_CR31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","volume":"51","author":"S Groesch","year":"2012","unstructured":"Groesch S, Schiffmann S, Geisslinger G (2012) Chain length-specific properties of ceramides. Prog Lipid Res 51:50\u201362","journal-title":"Prog Lipid Res"},{"key":"8402_CR32","doi-asserted-by":"crossref","first-page":"053716","DOI":"10.1063\/1.2737770","volume":"78","author":"I Klinkert","year":"2007","unstructured":"Klinkert I, McDonnell LA, Luxembourg SL, Altelaar AFM, Amstalden ER, Piersma SR, Heeren RMA (2007) Tools and strategies for visualization of large image data sets in high-resolution imaging mass spectrometry. Rev Sci Instrum 78:053716","journal-title":"Rev Sci Instrum"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-014-8402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-014-8402-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-014-8402-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T13:19:02Z","timestamp":1558617542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-014-8402-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,27]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["8402"],"URL":"https:\/\/doi.org\/10.1007\/s00216-014-8402-7","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,27]]}}}